1. Search Result

Search Result

Results for "1902954-60-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-109079


    Proton Pump Metabolic Disease
    Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H +, K +- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases.